| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.593 | 24.989 | 30.203 | 42.620 | 41.785 | 55.008 | 80.380 | 99.544 | 126.365 |
| Total Income - EUR | - | 6.593 | 24.989 | 30.203 | 42.620 | 41.785 | 55.008 | 80.380 | 99.544 | 126.365 |
| Total Expenses - EUR | - | 50 | 90 | 7.314 | 776 | 5.542 | 12.958 | 13.530 | 23.802 | 21.765 |
| Gross Profit/Loss - EUR | - | 6.543 | 24.899 | 22.888 | 41.844 | 36.243 | 42.050 | 66.851 | 75.742 | 104.601 |
| Net Profit/Loss - EUR | - | 6.345 | 24.149 | 21.982 | 40.566 | 34.990 | 40.400 | 64.439 | 74.746 | 100.886 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Obderm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 812 | 35.603 | 25.993 | 17.226 | 10.137 | 3.238 |
| Current Assets | - | 6.535 | 30.726 | 52.148 | 90.943 | 26.110 | 74.681 | 79.177 | 90.661 | 174.469 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 414 | 11.510 | 84.084 |
| Cash | - | 6.535 | 30.726 | 52.148 | 90.943 | 26.110 | 74.681 | 78.763 | 79.151 | 90.385 |
| Shareholders Funds | - | 6.390 | 30.431 | 51.855 | 91.416 | 62.652 | 101.662 | 95.445 | 100.155 | 100.934 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 145 | 295 | 294 | 338 | 465 | 511 | 2.462 | 868 | 77.014 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Obderm Srl